Raymond James Financial’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Raymond James Financial's AMRX Position: Q3 2026 in Review
Raymond James Financial increased its Amneal Pharmaceuticals (AMRX) stake by 12% in Q3 2026, buying an estimated $1.75M and bringing the position to 874,367 shares worth $17.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1646.
Raymond James Financial first reported a position in AMRX in Q4 2024 and has held it in 8 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Raymond James Financial held 874,367 shares of Amneal Pharmaceuticals worth $17.6M as of Q3 2026.
- Raymond James Financial bought 97,099 Amneal Pharmaceuticals shares in Q3 2026, an estimated $1.75M.
- Amneal Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #1646 holding.
- Raymond James Financial first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.